Mark Kaye's most recent trade in Conmed Corp. was a trade of 8,061 Options To Purchase Common Stock done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conmed Corp. | Mark B. Kaye | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 8,061 | 8,061 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Mark B. Kaye | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 668 | 668 | - | - | RSUs (Restricted Stock Units) | |
| Elevance Health | Mark B. Kaye | EVP & CFO | Sale of securities on an exchange or to another person at price $ 424.82 per share. | 24 Apr 2025 | 4,588 | 18,977 (0%) | 0% | 424.8 | 1,949,074 | Common Stock |
| Elevance Health | Mark B. Kaye | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 13,713 | 13,713 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Mark B. Kaye | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,604 | 23,565 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 270 | 19,961 (0%) | 0% | 395.5 | 106,785 | Common Stock |
| Conmed Corp. | Mark B. Kaye | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 1,846 | 1,846 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Mark B. Kaye | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 152 | 152 | - | - | RSUs (Restricted Stock Units) | |
| Elevance Health | Mark B. Kaye | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 505.16 per share. | 02 Oct 2024 | 2,818 | 20,213 (0%) | 0% | 505.2 | 1,423,541 | Common Stock |
| Elevance Health | Mark Kaye B. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 10,633 | 10,633 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Mark Kaye B. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,755 | 23,031 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Mark Kaye | EVP & CFO Designate | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 18,174 | 18,174 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Mark Kaye | EVP & CFO Designate | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 8,076 | 8,076 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Mark Kaye | EVP & CFO Designate | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 2,102 | 20,276 (0%) | 0% | 0 | Common Stock | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 3,857 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 340.81 per share. | 07 Aug 2023 | 3,857 | 4,447 (0%) | 0% | 340.8 | 1,314,520 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 276.84 per share. | 07 Aug 2023 | 3,857 | 8,304 (0%) | 0% | 276.8 | 1,067,772 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 341.10 per share. | 07 Aug 2023 | 3,832 | 4,447 (0%) | 0% | 341.1 | 1,307,097 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 3,470 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 340.88 per share. | 07 Aug 2023 | 3,470 | 4,447 (0%) | 0% | 340.9 | 1,182,855 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 280.42 per share. | 07 Aug 2023 | 3,470 | 7,917 (0%) | 0% | 280.4 | 973,057 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.58 per share. | 07 Aug 2023 | 1,741 | 6,188 (0%) | 0% | 173.6 | 302,203 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 1,741 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 341.22 per share. | 07 Aug 2023 | 1,741 | 4,447 (0%) | 0% | 341.2 | 594,058 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 1,544 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 340.89 per share. | 07 Aug 2023 | 1,544 | 4,447 (0%) | 0% | 340.9 | 526,334 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 325.99 per share. | 07 Aug 2023 | 1,544 | 5,991 (0%) | 0% | 326.0 | 503,329 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 714 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 341.04 per share. | 07 Aug 2023 | 714 | 4,447 (0%) | 0% | 341.0 | 243,503 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 277.05 per share. | 07 Aug 2023 | 714 | 5,161 (0%) | 0% | 277.1 | 197,814 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 344.19 per share. | 03 Jul 2023 | 43 | 8,279 (0%) | 0% | 344.2 | 14,800 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 317.91 per share. | 19 May 2023 | 975 | 8,322 (0%) | 0% | 317.9 | 309,962 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 5,537 | 12,723 (0%) | 0% | 0 | Common Stock | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 290.63 per share. | 01 Mar 2023 | 3,426 | 9,297 (0%) | 0% | 290.6 | 995,698 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 5,757 | 5,757 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 295.33 per share. | 21 Feb 2023 | 1,845 | 7,186 (0%) | 0% | 295.3 | 544,884 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 1,740 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 322.25 per share. | 15 Aug 2022 | 1,740 | 5,341 (0%) | 0% | 322.3 | 560,715 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.58 per share. | 15 Aug 2022 | 1,740 | 7,081 (0%) | 0% | 173.6 | 302,029 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 322.25 per share. | 15 Aug 2022 | 1,374 | 5,341 (0%) | 0% | 322.3 | 442,772 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 1,374 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 156.14 per share. | 15 Aug 2022 | 1,374 | 6,715 (0%) | 0% | 156.1 | 214,536 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.81 per share. | 01 Jul 2022 | 43 | 5,341 (0%) | 0% | 272.8 | 11,731 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 325.24 per share. | 02 Mar 2022 | 3,702 | 5,384 (0%) | 0% | 325.2 | 1,204,038 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 7,285 | 13,465 (0%) | 0% | 0 | Common Stock | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 323.88 per share. | 01 Mar 2022 | 4,379 | 9,086 (0%) | 0% | 323.9 | 1,418,271 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 6,179 | 6,179 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 325.99 per share. | 17 Feb 2022 | 1,595 | 6,180 (0%) | 0% | 326.0 | 519,954 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 398.28 per share. | 18 Nov 2021 | 316 | 4,585 (0%) | 0% | 398.3 | 125,856 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 1,734 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 379.69 per share. | 16 Aug 2021 | 1,734 | 4,901 (0%) | 0% | 379.7 | 658,382 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 280.42 per share. | 16 Aug 2021 | 1,734 | 6,635 (0%) | 0% | 280.4 | 486,248 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 379.69 per share. | 16 Aug 2021 | 1,043 | 4,901 (0%) | 0% | 379.7 | 396,017 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 356 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 379.69 per share. | 16 Aug 2021 | 356 | 4,901 (0%) | 0% | 379.7 | 135,170 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 277.05 per share. | 16 Aug 2021 | 356 | 5,257 (0%) | 0% | 277.1 | 98,630 | Common Stock |
| Moody's | Mark Kaye | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 363.42 per share. | 01 Jul 2021 | 45 | 5,944 (0%) | 0% | 363.4 | 16,354 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 1,740 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 325.08 per share. | 20 May 2021 | 1,740 | 5,989 (0%) | 0% | 325.1 | 565,639 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.58 per share. | 20 May 2021 | 1,740 | 7,729 (0%) | 0% | 173.6 | 302,029 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 156.14 per share. | 20 May 2021 | 595 | 6,584 (0%) | 0% | 156.1 | 92,903 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 595 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 325.08 per share. | 20 May 2021 | 595 | 5,989 (0%) | 0% | 325.1 | 193,423 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 3,624 | 9,394 (0%) | 0% | 0 | Common Stock | |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 280.63 per share. | 01 Mar 2021 | 2,340 | 7,054 (0%) | 0% | 280.6 | 656,674 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 280.85 per share. | 01 Mar 2021 | 1,065 | 5,989 (0%) | 0% | 280.8 | 299,105 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 7,715 | 7,715 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 276.84 per share. | 22 Feb 2021 | 1,878 | 5,770 (0%) | 0% | 276.8 | 519,906 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 280.08 per share. | 16 Feb 2021 | 778 | 3,892 (0%) | 0% | 280.1 | 217,902 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 156.14 per share. | 16 Feb 2021 | 778 | 4,670 (0%) | 0% | 156.1 | 121,477 | Common Stock |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 778 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moody's | Mark Kaye | SVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 273.43 per share. | 11 Nov 2020 | 1,812 | 3,892 (0%) | 0% | 273.4 | 495,455 | Common Stock |